Optimization of Surgical Procedure and Efficacy Evaluation of Aortic Calcification Model in Rats with Chronic Kidney Disease

doi:10.12300/j.issn.1674-5817.2024.128

Abstract

Abstract:

Objective To establish a chronic kidney disease-associated aortic calcification model in SD rats using different nephrectomy surgical methods, and to compare and evaluate surgical duration and survival time to explore a more optimized modeling method. Methods According to different surgical methods, the SD rats were divided into four groups: Group A: intraperitoneal resection of 2/3 of the left kidney followed by right total nephrectomy in the second stage; Group B: intraperitoneal resection of 2/3 of the left kidney and simultaneous right total nephrectomy; Group C: dorsal approach right total nephrectomy followed by resection of 2/3 of the left kidney in the second stage; Group D: dorsal approach resection of 2/3 of the left kidney followed by right total nephrectomy in the second stage. After comparing survival curves of SD rats undergoing intraperitoneal versus dorsal approaches, and staged versus single-stage nephrectomy, the optimal nephrectomy surgical method was determined. Then, twenty-four 8-week-old SPF-grade male SD rats were selected for nephrectomy combined with calcitriol-induced calcification. Experimental group (12 rats): the dorsal approach left 2/3 nephrectomy followed by right total nephrectomy, with intraperitoneal injection of 1 μg/kg calcitriol administered one week later to induce aortic calcification. Control group (12 rats): the intraperitoneal injection of 250 μL/kg physiological saline containing 1% DMSO one week after sham surgery. After intraperitoneal injection of drugs for 3 months, the survival status of rats in each group was observed. Under anesthesia, blood samples were collected from each group to measure serum phosphorus and calcium ion concentrations, as well as serum urea nitrogen and creatinine levels. After euthanizing the rats, a post-mortem examination was performed to observe the residual kidney morphology, and HE staining was used to observe the pathological changes in the coronal section of the kidney. Additionally, the entire aorta of each group was taken, and the degree of aortic calcification was observed by staining with Alizarin red S and von Kossa. Real-time fluorescence quantitative PCR was used to detect the gene expression of smooth muscle actin-associated protein alpha (Sm22), Runt-related transcription factor 2 (Runx2), and osteopontin (OPN) in rat aortic tissue to evaluate the effectiveness of the model. Results The exploratory optimization experiment of different surgical procedures found that the survival rate of group D rats,which underwent 2/3 left kidney resection followed by right whole kidney resection via the dorsal approach, was the highest, indicating that this surgical procedure was the best method for establishing a chronic kidney disease model with renal dysfunction. The experimental group rats treated with this surgical procedure combined with high-dose calcitriol injection had significantly lower serum calcium ion concentration than those in the sham-operated control group (P<0.05), while serum phosphorus ion concentration, serum creatinine, and serum urea nitrogen levels were significantly higher than those of the control group (P<0.05). HE staining of the kidneys showed significant organic changes in the kidneys of the experimental group rats, with a significant decrease in glomerular count compared to that of the control group (P<0.05), indicating the successful establishment of a renal failure model. Alizarin red S staining showed significant pigment deposition in the aortic media of the experimental group rats, while von Kossa staining showed significant silver nitrate deposition in the aortic media of the experimental group rats, which was consistent with the manifestation of aortic calcification in renal failure. Real-time fluorescence quantitative PCR showed that the expression level of Sm22 in the aortic tissue of the experimental group rats decreased (P<0.05), while the expression levels of OPN and Runx2 increased (P<0.05), indicating a transition of aortic smooth muscle cells from smooth muscle phenotype to bone-like phenotype and successful induction of an aortic calcification model. Conclusion The method of establishing an aortic calcification model of chronic kidney disease in SD rats by first removing two-thirds of the left kidney via the dorsal approach followed by right total nephrectomy, combined with high-dose calcitriol administration, shortens the surgical time, improves the success rate of modeling, and increases the animal survival rate.

Key words: Vascular calcification, Chronic kidney disease, Nephrectomy, Animal models, SD rats

CLC Number:

Q95-33

PAN Yicong,JIANG Wenhong,HU Ming,et al. Optimization of Surgical Procedure and Efficacy Evaluation of Aortic Calcification Model in Rats with Chronic Kidney Disease[J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 279-289. DOI: 10.12300/j.issn.1674-5817.2024.128.

Figures/Tables 7

References 25

[1]	HUANG A R, GUO G Y, YU Y Q, et al. The roles of collagen in chronic kidney disease and vascular calcification[J]. J Mol Med, 2021, 99(1):75-92. DOI:10.1007/s00109-020-02014-6 .
[2]	李贵森. 2019年«中国慢性肾脏病矿物质和骨异常诊治指南»解读[J]. 诊断学理论与实践, 2020, 19(3):229-231. DOI: 10.16150/j.1671-2870.2020.03.005 .
	LI G S. Interpretation of Chinese Guideline for Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (2019 version)[J]. J Diagn Concepts Pract, 2020, 19(3):229-231. DOI: 10.16150/j.1671-2870.2020.03.005 .
[3]	YE Y Z, CHEN A, LI L, et al. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification[J]. Kidney Int. 2022 102(6):1259-1275. DOI:10.1016/j.kint.2022.07.034 .
[4]	柳潇雨. Shox2促进血管钙化的作用及机制研究[D]. 广州: 南方医科大学, 2023. DOI:10.27003/d.cnki.gojyu.2023.000180 .
	LIU X Y. The role and mechanism of Shox2 in promoting vascular calcification[D]. Guangzhou: Southern Medical University, 2023. DOI:10.27003/d.cnki.gojyu.2023.000180 .
[5]	阙冬冬. 五羟色胺对慢性肾脏病大鼠血管钙化的作用及其机制研究[D]. 广州: 南方医科大学, 2023. DOI:10.27003/d.cnki.gojyu.2023.000170 .
	QUE D D. Study on the effect and mechanism of serotonin on vascular calcification in rats with chronic kidney disease [D]. Guangzhou: Southern Medical University, 2023. DOI:10.27003/d.cnki.gojyu.2023.000170 .
[6]	冯丽芸. 二氢杨梅素抑制慢性肾脏病大鼠血管钙化及其机制研究[D]. 广州: 南方医科大学, 2022. DOI:10.27003/d.cnki.gojyu.2022.000227 .
	FENG L Y. Study on the inhibition of vascular calcification and its mechanism by dihydromyricetin in rats with chronic kidney disease [D]. Guangzhou: Southern Medical University, 2022. DOI:10.27003/d.cnki.gojyu.2022.000227 .
[7]	SHOBEIRI N, ADAMS M A, HOLDEN R M. Vascular calcification in animal models of CKD: a review[J]. Am J Nephrol, 2010, 31(6):471-481. DOI:10.1159/000299794 .
[8]	LIU Y J, GUO Y, BAO S M, et al. Bone marrow mesenchymal stem cell-derived exosomal microRNA-381-3p alleviates vascular calcification in chronic kidney disease by targeting NFAT5[J]. Cell Death Dis, 2022, 13(3):278. DOI:10.1038/s41419-022-04703-1 .
[9]	苏培培. 不同剂量骨化三醇对慢性肾衰竭大鼠主动脉钙化的影响[D]. 唐山: 华北理工大学, 2021. DOI:10.27108/d.cnki.ghelu.2021.000272 .
	SU P P. Effects of different doses of calcitriol on aortic calcification in rats with chronic renal failure [D]. Tangshan: North China University of Science and Technology, 2021. DOI:10.27108/d.cnki.ghelu.2021.000272 .
[10]	WU X J, SHEN S J, WU J Y, et al. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi[J]. Open Med, 2023, 18(1):20230861. DOI:10.1515/med-2023-0861 .
[11]	CHEN C Z, LI Y D, LU H L, et al. Curcumin attenuates vascular calcification via the exosomal miR-92b-3p/KLF4 axis[J]. Exp Biol Med, 2022, 247(16):1420-1432. DOI:10.1177/1535370222 1095456 .
[12]	LIU X Y, CHEN A, LIANG Q C, et al. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway[J]. Aging Cell, 2021, 20(6): e13377. DOI:10.1111/acel.13377 .
[13]	ZHANG X L, LI Y N, YANG P Z, et al. Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-κB (nuclear factor κB) signals[J]. Arterioscler Thromb Vasc Biol, 2020, 40(3):751-765. DOI:10.1161/ATVBAHA.119.313414 .
[14]	ROWE P S, MCCARTHY E M, YU A L, et al. Correction of vascular calcification and hyperphosphatemia in CKD rats treated with ASARM peptide[J]. Kidney360, 2022, 3(10):1683-1698. DOI:10.34067/KID.0002782022 .
[15]	MA W Q, SUN X J, ZHU Y, et al. PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming[J]. Cell Death Dis, 2020, 11(11):991. DOI:10.1038/s41419-020-03162-w .
[16]	SATO H, GOTO M, NISHIMURA G, et al. Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model[J]. Bone, 2023, 167:116613. DOI:10.1016/j.bone.2022.116613 .
[17]	LI Z H, WU J, ZHANG X L, et al. CDC42 promotes vascular calcification in chronic kidney disease[J]. J Pathol, 2019, 249(4):461-471. DOI:10.1002/path.5334 .
[18]	CHANG J R, GUO J, WANG Y, et al. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho[J]. Kidney Int, 2016, 89(3):586-600. DOI:10.1016/j.kint.2015.12.029 .
[19]	LEE S J, LEE I K, JEON J H. Vascular calcification-new insights into its mechanism[J]. Int J Mol Sci, 2020, 21(8):2685. DOI:10.3390/ijms21082685 .
[20]	张佳莉, 张岩. 急性肾损伤动物模型构建方法与研究现状[J]. 中国实验动物学报, 2022, 30(7):955-965. DOI: 10.3969/j.issn.1005-4847.2022.07.011 .
	ZHANG J L, ZHANG Y. Research approaches and status of animal models for acute kidney injury[J]. Acta Lab Anim Sci Sin, 2022, 30(7):955-965. DOI: 10.3969/j.issn.1005-4847.2022.07.011 .
[21]	陈娟, 易香伶, 罗佳, 等. 急性肾损伤动物模型及体外模型研究进展[J]. 华西医学, 2023, 38(5):777-783. DOI:10.7507/1002-0179.202210185 .
	CHEN J, YI X L, LUO J, et al. Advances in animal models and in vitro models of acute kidney injury[J]. West China Med J, 2023, 38(5):777-783. DOI:10.7507/1002-0179.202210185 .
[22]	HERRMANN J, BABIC M, TÖLLE M, et al. Research models for studying vascular calcification[J]. Int J Mol Sci, 2020, 21(6):2204. DOI:10.3390/ijms21062204 .
[23]	BAO Y W, YUAN Y, CHEN J H, et al. Kidney disease models: tools to identify mechanisms and potential therapeutic targets[J]. Zool Res, 2018, 39(2):72-86. DOI:10.24272/j.issn.2095-8137.2017.055 .
[24]	FU Y, TANG C Y, CAI J, et al. Rodent models of AKI-CKD transition[J]. Am J Physiol Renal Physiol, 2018, 315(4):F1098-F1106. DOI:10.1152/ajprenal.00199.2018 .
[25]	HERRMANN J, GUMMI M R, XIA M D, et al. Vascular calcification in rodent models-keeping track with an extented method assortment[J]. Biology, 2021, 10(6):459. DOI:10.3390/biology10060459 .

目标基因名称 Target gene name	NCBI基因序列号 NCBI reference sequence	引物序列信息 Primer sequence information	扩增片段大小/bp Amplification fragment size/bp
Sm22 (Tagln)	NC-086026.1	F：5’-CAGATGGAACAGGTGGCTCAA-3’	161
		R：5’-GCCCAAAGCCATTACAGTCCTC-3’
OPN (Spp1)	NC-086032.1	F：5’-GCCGAGGTGATAGCTTGGCTTA-3’	145
		R：5’-TTGATAGCCTCATCGGACTCCTG-3’
Runx2	NC-086027.1	F：5’-GGATGCCTTAGTGCCCAAATG-3’	120
		R：5’-CACCCTGTGAGGTGGCTGAA-3’
β-actin	NC-086030.1	F：5’-CACCCGCGAGTACAACCTTC-3’	207
		R：5’-CCCATACCCACCATCACACC-3’

目标基因名称 Target gene name	NCBI基因序列号 NCBI reference sequence	引物序列信息 Primer sequence information	扩增片段大小/bp Amplification fragment size/bp
Sm22 (Tagln)	NC-086026.1	F：5’-CAGATGGAACAGGTGGCTCAA-3’	161
		R：5’-GCCCAAAGCCATTACAGTCCTC-3’
OPN (Spp1)	NC-086032.1	F：5’-GCCGAGGTGATAGCTTGGCTTA-3’	145
		R：5’-TTGATAGCCTCATCGGACTCCTG-3’
Runx2	NC-086027.1	F：5’-GGATGCCTTAGTGCCCAAATG-3’	120
		R：5’-CACCCTGTGAGGTGGCTGAA-3’
β-actin	NC-086030.1	F：5’-CACCCGCGAGTACAACCTTC-3’	207
		R：5’-CCCATACCCACCATCACACC-3’

血生化指标 Biochemistry index	实验组（n=9） Experimental group	对照组（n=12） Control group	t值 t value	P值 P value
血清钙 c/(mmol·L^-1) Serum calcium ions	1.876±0.036	1.929±0.042	3.431	0.004
血清磷c/(mmol·L^-1) Serum phosphate ions	2.059±0.333	1.580±0.271	3.046	0.014
血清肌酐c/(μmol·L^-1) Serum creatinine	119.960±35.640	21.164±8.076	8.984	<0.000 1
血清尿素氮c/(mmol·L^-1) Serum urea nitrogen	57.991±8.745	22.609±8.058	6.895	<0.000 1

血生化指标 Biochemistry index	实验组（n=9） Experimental group	对照组（n=12） Control group	t值 t value	P值 P value
血清钙 c/(mmol·L^-1) Serum calcium ions	1.876±0.036	1.929±0.042	3.431	0.004
血清磷c/(mmol·L^-1) Serum phosphate ions	2.059±0.333	1.580±0.271	3.046	0.014
血清肌酐c/(μmol·L^-1) Serum creatinine	119.960±35.640	21.164±8.076	8.984	<0.000 1
血清尿素氮c/(mmol·L^-1) Serum urea nitrogen	57.991±8.745	22.609±8.058	6.895	<0.000 1